Cargando…
MicroRNA-7 sensitizes non-small cell lung cancer cells to paclitaxel
Paclitaxel (PTX) is the front-line chemotherapeutic agent against human non-small cell lung cancer (NSCLC). However, its therapeutic efficacy is restricted by the increasing frequency of chemotherapeutic resistance in NSCLC. Accumulating evidence has shown the potential role of microRNAs (miRNAs) in...
Autores principales: | LIU, RONGHUA, LIU, XIAOMING, ZHENG, YIJIE, GU, JIE, XIONG, SHUDAO, JIANG, PEI, JIANG, XUECHAO, HUANG, ENYU, YANG, YIXIAN, GE, DI, CHU, YIWEI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186567/ https://www.ncbi.nlm.nih.gov/pubmed/25289099 http://dx.doi.org/10.3892/ol.2014.2500 |
Ejemplares similares
-
MicroRNA-7 Inhibits the Growth of Human Non-Small Cell Lung Cancer A549 Cells through Targeting BCL-2
por: Xiong, Shudao, et al.
Publicado: (2011) -
STAT6 deficiency ameliorates Graves' disease severity by suppressing thyroid epithelial cell hyperplasia
por: Jiang, Xuechao, et al.
Publicado: (2016) -
Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel
por: CHEN, NING, et al.
Publicado: (2014) -
MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer
por: Shen, Hua, et al.
Publicado: (2016) -
Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway
por: Xu, Fengkai, et al.
Publicado: (2016)